This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Autism
F5_AUTISM
autism: A disorder characterized by marked impairments in social interaction and communication accompanied by a pattern of repetitive, stereotyped behaviors and activities. Developmental delays in social interaction and language surface prior to age 3 years.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1282 |
4. Check minimum number of eventsNone |
1282 |
5. Include endpointsNone |
1282 |
6. Filter based on genotype QC (FinnGen only) |
1138 |
Control definitions (FinnGen only)
- Control exclude
- F5_PSYCHDEV
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Autism
based on the number of shared cases.
Similar with more cases:
- Wide developmental disorders
- Wide developmental disorders, excluding more controls
- Disorders of psychological development
- Any mental disorder
- Psychiatric diseases
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1138 | 594 | 544 |
| Unadjusted period prevalence (%) | 0.23 | 0.21 | 0.25 |
| Median age at first event (years) | 25.54 | 27.82 | 23.05 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1206
- Matched controls
- 12054
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F84.5
ICD-10 Finland
Asperger syndrome
4815.5
307.7
1083
22
N06BA04
ATC
methylphenidate; oral
10.3
307.7
480
728
F90.0
ICD-10 Finland
Disturbance of activity and attention
11.1
307.7
548
838
N05AX08
ATC
risperidone; systemic
10.9
263.1
330
404
N05AH04
ATC
quetiapine; oral
6.3
223.9
606
1664
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.7
184.6
501
1344
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
10.8
170.7
200
218
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
7.7
170.3
277
451
N05AX12
ATC
aripiprazole; systemic
7.4
167.9
282
475
N06AX12
ATC
bupropion; oral
6.0
162.7
365
817
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
7.0
162.0
288
514
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
8.1
158.2
239
357
F32.9
ICD-10 Finland
Depressive episode, unspecified
4.8
147.7
482
1467
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
327.9
144.9
144
5
F29
ICD-10 Finland
Unspecified nonorganic psychosis
7.6
142.1
226
356
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
7.0
136.9
235
401
ZY010
NOMESCO Finland
Hospital outpatient
6.1
136.7
280
569
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
5.9
136.0
291
616
N05AH03
ATC
olanzapine; systemic
6.1
135.2
274
551
F84.0
ICD-10 Finland
Childhood autism
+∞
133.9
126
*
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
8.3
129.5
186
260
N06AX16
ATC
venlafaxine; oral
4.8
126.0
374
1041
N06BA12
ATC
lisdexamfetamine; oral
8.8
117.2
158
204
Z2445
NOMESCO Finland
Psychologist
6.2
116.6
228
440
N06AB03
ATC
fluoxetine; oral
5.0
115.5
298
736
N06AB06
ATC
sertraline; oral
4.4
114.9
380
1141
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
4.4
107.9
341
985
ZYC01
NOMESCO Finland
Remote contact by phone
6.0
107.3
215
423
N03AX09
ATC
lamotrigine; oral
5.9
107.0
216
428
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
13.3
95.8
93
75
IGV01
NOMESCO Finland
Psychiatric network contact
10.2
95.6
112
120
F83
ICD-10 Finland
Mixed specific developmental disorders
500.3
94.7
93
*
P29
ICPC
Psychological sympt/compl other
3.9
94.3
357
1164
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
5.2
91.5
214
481
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
7.8
90.5
133
189
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.5
90.4
444
1713
Z2446
NOMESCO Finland
Social worker
4.9
90.2
229
551
N06AB10
ATC
escitalopram; oral
3.4
89.7
505
2118
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
5.2
87.5
202
448
N05BA04
ATC
oxazepam; oral
3.5
85.9
416
1583
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
5.3
85.4
192
416
P99
ICPC
Psychological disorders other
6.4
85.3
152
265
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
5.4
84.3
183
384
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
7.9
84.3
121
167
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
4.5
83.8
236
615
F34.1
ICD-10 Finland
Dysthymia
6.4
82.7
148
259
F84.8
ICD-10 Finland
Other pervasive developmental disorders
+∞
82.2
78
*
N06AX26
ATC
vortioxetine; oral
4.0
79.2
272
819
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
5.2
77.3
175
380
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
5.7
75.0
152
299
F93.89
ICD-10 Finland
Other childhood emotional disorders
7.4
71.3
108
158
SPAT1240
SPAT
Therapeutic discussion
3.3
70.8
346
1304
N03AG01
ATC
valproic acid; systemic, rectal
5.2
68.9
153
326
IGY99
NOMESCO Finland
Other psychiatric treatment contact
5.5
68.6
142
284
N06AX11
ATC
mirtazapine; oral
2.9
67.6
487
2278
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
5.0
65.0
153
342
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
5.1
64.9
147
318
SPAT1307
SPAT
Psychosocial counselling and guidance
3.3
63.6
295
1070
ZYY79
NOMESCO Finland
Other indirect service without contact with patient
15.6
61.7
54
36
N06AB04
ATC
citalopram; systemic
3.5
60.6
255
868
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
6.0
58.8
109
196
F61.0
ICD-10 Finland
Mixed personality disorders
8.0
57.8
81
108
F40.1
ICD-10 Finland
Social phobias
4.3
57.1
164
428
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
5.4
56.1
116
231
N06AX21
ATC
duloxetine; oral
3.7
55.8
203
627
N05AB03
ATC
perphenazine; systemic, rectal
6.9
55.4
88
135
F41.1
ICD-10 Finland
Generalized anxiety disorder
3.4
55.2
231
781
IGY02
NOMESCO Finland
Psychiatric monitoring contact
4.2
54.0
160
427
N06BA09
ATC
atomoxetine; oral
10.0
53.4
62
65
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
6.1
52.8
96
169
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
12.0
52.7
54
47
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
8.2
52.7
72
93
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.5
52.4
139
341
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
6.6
51.5
86
139
F64.9
ICD-10 Finland
Gender identity disorder, unspecified
11.5
50.4
53
48
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
7.0
48.0
75
113
F99
ICD-10 Finland
Mental disorder, not otherwise specified
6.0
47.9
87
153
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
6.0
46.6
85
150
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.2
46.4
133
345
P03
ICPC
Feeling depressed
2.6
46.4
353
1645
P76
ICPC
Depressive disorder
3.1
44.3
217
800
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.0
44.2
134
362
P01
ICPC
Feeling anxious/nervous/tense
2.4
44.2
472
2562
XA800
NOMESCO Finland
Neuropsychological investigation
5.1
44.1
98
207
IBZ08
NOMESCO Finland
Gender identity assessment
12.3
43.0
43
36
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
9.6
42.9
51
55
OAB43, ,
SPAT
0.4
42.5
243
4876
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.4
42.3
112
273
F80.2
ICD-10 Finland
Receptive language disorder
222.6
42.2
43
*
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
5.2
41.6
89
182
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.4
41.1
108
262
F60.9
ICD-10 Finland
Personality disorder, unspecified
7.4
40.5
60
85
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
4.1
40.5
119
314
F80.1
ICD-10 Finland
Expressive language disorder
144.8
40.0
42
*
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.5
39.9
327
1564
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
4.6
39.7
99
230
ICB06, ,
NOMESCO Finland
7.2
39.7
60
87
SPAT1389
SPAT
Visit based on need for special support
3.3
39.2
164
548
F21
ICD-10 Finland
Schizotypal disorder
14.2
39.2
36
26
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.0
38.3
117
317
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
6.1
38.2
68
117
F82
ICD-10 Finland
Specific developmental disorder of motor function
201.2
38.0
39
*
IEV99
NOMESCO Finland
Other psychiatric network intervention
7.4
37.9
56
79
P81
ICPC
Hyperkinetic disorder
5.0
37.6
84
178
F33.8
ICD-10 Finland
Other recurrent depressive disorders
8.5
37.4
49
60
IGP01
NOMESCO Finland
Psychiatric family contact
5.7
37.1
71
131
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
9.1
36.5
45
51
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
5.9
35.9
66
117
F43.1
ICD-10 Finland
Post-traumatic stress disorder
3.8
35.5
114
320
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
9.6
35.5
42
45
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
9.6
35.5
42
45
SPAT1243
SPAT
Psychiatric/psychological examination
3.7
35.3
119
345
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
11.9
35.3
36
31
N06AX22
ATC
agomelatine; oral
4.8
35.2
83
184
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
4.6
35.1
86
197
N05AF03
ATC
chlorprothixene; systemic
6.2
34.9
61
103
N05AE04
ATC
ziprasidone; systemic
9.8
34.3
40
42
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
346.4
34.1
34
*
Z3231
NOMESCO Finland
Registered nurse
2.2
33.7
371
1997
F42.0
ICD-10 Finland
Predominantly obsessional thoughts or ruminations
7.1
33.7
51
74
N05AD01
ATC
haloperidol; systemic
7.5
33.6
49
68
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
5.4
33.6
68
132
ZXY83
NOMESCO Finland
Social worker in multidisciplinary team
10.9
33.2
36
34
Z07
ICPC
Education problem
5.2
33.2
70
141
F64.0
ICD-10 Finland
Transsexualism
11.2
33.0
35
32
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
120.0
32.8
35
*
N06AB05
ATC
paroxetine; oral
4.1
32.8
96
252
N05BA01
ATC
diazepam; systemic, rectal
3.1
32.6
150
529
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
9.8
32.5
38
40
ZY000
NOMESCO Finland
Hospital inpatient
5.7
32.5
62
114
F60.5
ICD-10 Finland
Anankastic personality disorder
7.1
32.4
49
71
F89
ICD-10 Finland
Unspecified disorder of psychological development
63.5
32.2
37
6
R4110, ,
SPAT
3.2
31.8
138
470
ZYY01
NOMESCO Finland
Contact between professionals
8.3
31.7
42
52
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
3.8
31.5
100
278
N05AN01
ATC
lithium; oral
5.0
31.4
69
144
F84.10
ICD-10 Finland
Autism in atypical age
+∞
31.4
30
*
C07AA05
ATC
propranolol; systemic
2.3
31.3
315
1627
R62.0
ICD-10 Finland
Delayed milestone
8.6
31.0
40
48
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
3.6
30.9
106
311
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
6.8
30.8
49
75
Z01.8
ICD-10 Finland
Other specified special examinations
2.4
30.6
266
1289
F60.6
ICD-10 Finland
Anxious [avoidant] personality disorder
8.4
30.5
40
49
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
5.3
30.4
63
125
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.4
30.1
79
191
P74
ICPC
Anxiety disorder/anxiety state
2.8
29.8
169
667
F50.8
ICD-10 Finland
Other eating disorders
9.7
29.8
35
37
F41.8
ICD-10 Finland
Other specified anxiety disorders
3.2
29.7
124
412
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
3.9
29.1
91
250
F39
ICD-10 Finland
Unspecified mood [affective] disorder
4.1
29.1
82
209
SPAT1234
SPAT
Support of social functional capacity
4.7
29.0
69
154
IGY02, ,
SPAT
4.9
28.8
65
139
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
5.8
28.0
52
93
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.6
28.0
98
291
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.9
28.0
145
545
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
6.5
27.9
46
73
N06BA02
ATC
dexamfetamine; oral
11.0
27.8
30
28
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
4.2
27.6
75
186
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
36.0
27.5
35
10
SPAT1396
SPAT
Meeting with multidisciplinary group of experts
5.7
27.4
52
95
ZXY81
NOMESCO Finland
Psychologist in multidisciplinary team
9.1
26.9
33
37
N05BE01
ATC
buspirone; oral
4.8
26.8
62
135
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
4.3
26.8
72
177
IER01
NOMESCO Finland
Psychoeducation, group
6.0
26.8
48
83
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
4.7
26.6
63
140
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
8.3
26.6
35
43
F88
ICD-10 Finland
Other disorders of psychological development
46.8
26.6
32
7
SPAT1284
SPAT
Extensive health certificate
3.9
26.6
80
214
N06AG02
ATC
moclobemide; oral
5.2
26.5
55
109
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.5
26.5
193
860
N05BA06
ATC
lorazepam; systemic, sublingual
4.8
26.4
61
133
IAB03
NOMESCO Finland
Neuropsychiatric consultation
52.9
26.3
31
6
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.2
26.3
276
1439
F84.11
ICD-10 Finland
Autism with atypical symptoms
+∞
26.1
25
*
SPAT1298
SPAT
Other function in accordance with nutritional therapy nomenclature
9.3
25.7
31
34
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.0
25.6
119
420
F32.1
ICD-10 Finland
Moderate depressive episode
2.5
25.6
173
744
F31
ICD-10 Finland
Bipolar affective disorder
5.9
25.5
46
80
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.7
25.2
152
617
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.9
25.0
75
200
IEP99
NOMESCO Finland
Other psychiatric family intervention
6.5
24.9
41
65
F50.9
ICD-10 Finland
Eating disorder, unspecified
4.6
24.7
60
136
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
8.8
24.6
31
36
N05AX16
ATC
brexpiprazole; oral
9.6
24.5
29
31
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
4.6
24.2
58
130
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
2.9
24.2
120
439
SPAT1310
SPAT
Counselling related to known health issue
1.9
24.0
458
2939
IEZ99
NOMESCO Finland
Other psychiatric rehabilitation intervention
8.3
23.6
31
38
R5599
NOMESCO Finland
Other rehabilitation service
4.9
23.5
52
109
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.0
23.4
107
374
IHZ04, ,
SPAT
4.1
23.0
65
166
M79.7
ICD-10 Finland
Fibromyalgia
4.4
23.0
59
140
OAA68, ,
SPAT
5.2
22.9
48
96
N05AA02
ATC
levomepromazine; systemic
4.1
22.9
64
162
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
5.7
22.8
43
78
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.9
22.7
114
420
ZYC02
NOMESCO Finland
Remote contact by video link
9.5
22.7
27
29
G47.3
ICD-10 Finland
Sleep apnoea
2.3
22.6
200
967
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
6.9
22.6
35
52
T82
ICPC
Obesity
3.4
22.5
84
260
N03AE01
ATC
clonazepam; systemic
4.0
22.4
66
174
F20.9
ICD-10 Finland
Schizophrenia, unspecified
4.9
22.3
50
106
F33
ICD-10 Finland
Recurrent depressive disorder
3.6
22.2
76
222
N05AH02
ATC
clozapine; systemic
4.4
22.2
56
131
SPAT1139
SPAT
Nutrition survey
4.9
22.1
49
103
M35.7
ICD-10 Finland
Hypermobility syndrome
4.8
22.1
50
107
ZXY56
NOMESCO Finland
2-person team, nurse-psychologist
8.7
21.9
28
33
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
63.7
21.9
25
*
N04AA02
ATC
biperiden; systemic
6.5
21.9
36
57
P85
ICPC
Mental retardation
20.5
21.8
32
16
Z72.8
ICD-10 Finland
Other problems related to lifestyle
7.3
21.7
32
45
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.1
21.5
232
1213
F60.8
ICD-10 Finland
Other specific personality disorders
8.0
21.3
29
37
N06AA04
ATC
clomipramine; systemic
7.1
21.3
32
46
N06AX03
ATC
mianserin; oral
4.5
21.0
52
120
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
6.0
21.0
37
63
F81.0
ICD-10 Finland
Specific reading disorder
24.7
20.9
29
12
F95.2
ICD-10 Finland
Combined vocal and multiple motor tic disorder [de la Tourette]
21.9
20.9
30
14
SPAT1229
SPAT
Assessment of need for aid
4.7
20.7
48
105
N03AX11
ATC
topiramate; oral
4.1
20.6
57
143
IHZ05, ,
SPAT
2.3
20.6
172
810
P06
ICPC
Sleep disturbance
2.1
20.5
220
1146
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
6.6
20.5
33
51
W78
ICPC
Pregnancy
0.4
20.5
97
2301
F32
ICD-10 Finland
Depressive episode
2.6
20.5
126
515
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
4.8
20.4
46
98
ZXY49
NOMESCO Finland
Other health care provider
7.6
20.4
29
39
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.9
20.2
98
354
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
5.7
20.2
38
69
IEP03
NOMESCO Finland
Focused parental counselling
6.7
20.1
32
49
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
5.3
19.9
40
77
IEY01
NOMESCO Finland
Psychoeducation, individual
5.2
19.9
41
81
N02BF02
ATC
pregabalin; oral
3.1
19.8
85
286
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
5.4
19.7
39
74
P27
ICPC
Fear of mental disorder
4.3
19.7
52
126
N05BA12
ATC
alprazolam; oral
2.9
19.7
99
365
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
203.1
19.6
20
*
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
6.3
19.4
33
54
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
4.2
19.3
51
124
Z3226
NOMESCO Finland
Physiotherapist
2.1
19.2
196
1000
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.5
19.2
131
563
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
8.0
19.2
26
33
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
23.0
19.1
27
12
F41.3
ICD-10 Finland
Other mixed anxiety disorders
3.4
19.1
69
209
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
5.0
19.1
41
84
N06AX05
ATC
trazodone; oral
4.6
19.0
45
100
R1250, ,
SPAT
3.1
18.9
80
267
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
4.7
18.8
44
97
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.2
18.5
75
244
A28
ICPC
Limited function/disability NOS
3.1
18.1
78
263
T05
ICPC
Feeding problem of adult
4.7
18.1
42
92
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
17.9
208
1113
AA400
NOMESCO Finland
Electroconvulsive therapy
6.8
17.9
28
42
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.5
17.7
62
184
Z02.7
ICD-10 Finland
Issue of medical certificate
2.5
17.5
116
491
N05CF01
ATC
zopiclone; oral
2.0
17.5
218
1195
N05AE05
ATC
lurasidone; oral
7.5
17.4
25
34
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.5
17.3
156
2892
R1250
NOMESCO Finland
Evaluation of functional capability
5.3
17.3
35
68
N05AX15
ATC
cariprazine; oral
6.5
17.1
28
44
R5140
NOMESCO Finland
Monitoring the use of the aid
2.8
17.0
88
329
N06AB08
ATC
fluvoxamine; oral
6.3
16.8
28
45
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
4.2
16.7
45
111
F50.0
ICD-10 Finland
Anorexia nervosa
4.6
16.7
40
90
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
0.3
16.5
53
1534
F84.12
ICD-10 Finland
Autism both in atypical age and with atypical symptoms
172.2
16.5
17
*
N05CF02
ATC
zolpidem; oral
2.2
16.5
156
771
SPAT1051
SPAT
Guidance regarding sleep disorders
4.6
16.4
39
87
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.5
16.4
126
2481
K03.66
ICD-10 Finland
Tooth plaque
2.2
16.4
154
759
Z06
ICPC
Unemployment problem
5.3
16.3
33
64
P86
ICPC
Anorexia nervosa/bulimia
6.4
16.3
27
43
Z29
ICPC
Social problem NOS
3.4
16.3
58
174
F32.8
ICD-10 Finland
Other depressive episodes
3.7
16.3
52
145
SPAT1395
SPAT
Health check-up of persons outside student and working life
4.5
16.2
39
88
IBB03
NOMESCO Finland
Assessment of vocational rehabilitation needs in a mental health context
7.2
16.1
24
34
OAA80, ,
SPAT
0.3
16.0
42
1355
SPAT1301
SPAT
No procedures
1.7
15.9
370
2460
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
33.8
15.8
20
6
N03AX16
ATC
[U] pregabalin
2.1
15.5
157
795
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.2
15.5
133
631
Z75.1
ICD-10 Finland
Person awaiting admission to adequate facility elsewhere
4.5
15.5
38
87
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
4.6
15.5
37
83
IHZ07, ,
SPAT
6.5
15.4
25
39
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
15.0
15.4
25
17
183
Kela drug reimbursment
Lamotrigin and topiramate
6.0
15.3
27
46
A01
ICPC
Pain general/multiple sites
2.4
15.2
115
517
P79
ICPC
Phobia/compulsive disorder
4.6
15.0
35
77
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.5
14.9
96
401
F50.1
ICD-10 Finland
Atypical anorexia nervosa
5.3
14.9
30
58
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
2.3
14.8
114
517
3153A
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[KIELENKEHITYKSEN ERITYISVAIKEUS]
+∞
14.6
14
*
Z08
ICPC
Social welfare problem
4.9
14.5
32
67
K59.09
ICD-10 Finland
Constipation, unspecified
3.0
14.5
64
219
ZXY60
NOMESCO Finland
2-person team, nurses
5.6
14.3
27
49
SPAT1241
SPAT
Extensive assessment of psychosocial situation
3.6
14.2
48
139
IAZ99
NOMESCO Finland
Other psychiatric consultation
6.5
14.1
23
36
IBA01, ,
SPAT
2.8
14.1
70
256
N06AX17
ATC
milnacipran; oral
14.6
14.1
23
16
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
4.6
14.0
33
73
P72
ICPC
Schizophrenia
3.9
13.9
41
108
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.7
13.9
77
299
N06AX18
ATC
reboxetine; oral
12.2
13.6
24
20
SPAT1260
SPAT
Consultation of another employee
1.9
13.6
200
1154
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.5
13.5
87
363
R32
ICD-10 Finland
Unspecified urinary incontinence
5.6
13.4
25
45
R4120
NOMESCO Finland
Occupational therapy
2.7
13.4
73
281
IAA01, ,
SPAT
3.8
13.3
40
107
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.2
13.3
114
540
WZC00, ,
SPAT
1.8
13.3
245
1514
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
3.8
13.3
41
112
N05BA09
ATC
clobazam; oral
5.8
13.2
24
42
P98
ICPC
Psychosis NOS/other
5.2
13.2
27
53
A06AC01
ATC
ispaghula (psylla seeds); oral
1.9
13.2
173
961
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
0.5
13.1
123
2281
IGY99, ,
SPAT
2.3
13.0
103
472
SPAT1197
SPAT
Extensive health check-up of expecting family
0.4
13.0
79
1723
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
4.3
13.0
33
78
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.0
12.9
152
812
F98.9
ICD-10 Finland
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
5.7
12.9
24
43
F10.20
ICD-10 Finland
Alcohol dependence currently independent
4.6
12.9
30
66
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
4.8
12.9
29
62
P22
ICPC
Child behaviour symptom/complaint
3.5
12.8
44
129
F80.0
ICD-10 Finland
Specific speech articulation disorder
14.2
12.8
21
15
F32.01
ICD-10 Finland
Mild depressive episode with somatic syndrome
5.8
12.8
23
40
R4130
NOMESCO Finland
Speech therapy
4.4
12.7
32
75
Z00.0
ICD-10 Finland
General medical examination
1.7
12.7
269
1727
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
12.5
109
520
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
24.6
12.5
17
7
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.4
12.5
66
1526
F84.1
ICD-10 Finland
Atypical autism
131.3
12.5
13
*
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
4.1
12.4
34
85
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
4.9
12.4
27
56
Z39.2
ICD-10 Finland
Routine postpartum follow-up
0.4
12.3
86
1782
SPAT1312
SPAT
General health counselling
1.6
12.3
488
3652
P28
ICPC
Limited function/disability (P)
5.2
12.2
25
49
F79.1
ICD-10 Finland
Unspecified mental retardation, significant impairment of behaviour requiring attention or treatment
37.9
12.2
15
*
RT420, ,
NOMESCO Finland
16.0
12.2
19
12
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
0.3
12.1
25
931
IAZ98
NOMESCO Finland
Other internal psychiatric consultation
5.6
12.1
23
42
ZXY52
NOMESCO Finland
2-person team, doctor-psychologist
8.8
12.0
25
29
IER03
NOMESCO Finland
Psychiatric disorder-specific group intervention
8.8
12.0
25
29
F50.2
ICD-10 Finland
Bulimia nervosa
4.7
11.9
27
58
OAA43, ,
SPAT
2.6
11.9
71
286
OAA11, ,
SPAT
0.3
11.8
33
1037
IEY02
NOMESCO Finland
Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)
5.9
11.8
21
36
C07AB07
ATC
bisoprolol; oral
1.8
11.8
209
1274
WZA10, ,
SPAT
2.4
11.8
80
343
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.0
11.7
126
651
Z50.5
ICD-10 Finland
Speech therapy
4.1
11.7
32
80
MA3AE
NOMESCO Finland
Combined first trimester screening
0.3
11.7
24
895
F60.1
ICD-10 Finland
Schizoid personality disorder
19.1
11.6
17
9
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
11.2
11.6
21
19
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
11.2
11.6
21
19
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.6
11.5
336
2334
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
5.8
11.5
21
37
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.1
11.3
47
156
OAB48, ,
SPAT
0.5
11.3
117
2114
F41.09
ICD-10 Finland
UNS Panic Syndrome
2.4
11.2
76
325
SPAT1379
SPAT
Health check-up of pregnant person
0.4
11.2
71
1531
SPAT1058
SPAT
PEF monitoring instruction
2.3
11.2
83
370
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
11.1
571
4492
N06AA12
ATC
doxepin; systemic
3.8
11.1
33
88
RT150, ,
NOMESCO Finland
11.3
11.1
20
18
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
0.5
11.0
95
1829
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
5.8
11.0
20
35
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
4.4
11.0
27
62
N03AX12
ATC
[U] gabapentin; oral
2.1
11.0
108
540
A04
ICPC
Weakness/tiredness general
1.7
11.0
249
1622
R53
ICD-10 Finland
Malaise and fatigue
1.6
10.9
301
2060
TLC00
NOMESCO Finland
Insertion of intrauterine device
2.2
10.8
88
408
OAA12, ,
SPAT
0.2
10.7
16
729
P23
ICPC
Adolescent behaviour sympt/compl
3.5
10.7
37
109
L28
ICPC
Limited function/disability (L)
2.1
10.7
103
511
N03AF02
ATC
oxcarbazepine; oral
2.9
10.7
49
172
N05AE03
ATC
sertindole; oral
13.0
10.7
18
14
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.6
10.6
61
241
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
1.8
10.6
177
1057
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
8.1
10.6
23
29
N05CD07
ATC
temazepam; oral
3.3
10.6
39
120
IHZ04
NOMESCO Finland
Psychosocial counselling and guidance
11.3
10.6
19
17
F40.00
ICD-10 Finland
Agoraphobia without concomitant panic disorder
8.6
10.6
22
26
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
2.9
10.5
50
179
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
7.8
10.4
23
30
F94.9
ICD-10 Finland
Childhood disorder of social functioning, unspecified
32.8
10.3
13
*
M01AE01
ATC
ibuprofen; systemic, rectal
0.6
10.3
855
9536
ZXY03
NOMESCO Finland
Occupational therapist
8.0
10.1
22
28
SPAT1246
SPAT
Screening of depression or other psychiatric problem
2.0
10.0
109
566
WX307
NOMESCO Finland
Obstetric epidural analgesia
0.4
10.0
44
1109
F31.8
ICD-10 Finland
Other bipolar affective disorders
2.8
10.0
48
173
R4120, ,
SPAT
7.7
9.9
22
29
A02BC02
ATC
pantoprazole; systemic
1.5
9.9
522
4098
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
0.7
9.8
631
7450
F22.0
ICD-10 Finland
Delusional disorder
7.4
9.7
22
30
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.3
9.7
77
354
K59.0
ICD-10 Finland
Constipation
2.5
9.7
63
265
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
4.2
9.7
25
60
X78
ICD-10 Finland
Intentional self-harm by sharp object
3.8
9.6
29
78
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
9.6
211
1361
SPAT1053
SPAT
Memory test
4.8
9.5
21
44
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
4.6
9.5
22
48
SPAT1216
SPAT
Assessment of functional ability
2.1
9.5
91
450
F61
ICD-10 Finland
Mixed and other personality disorders
15.2
9.5
15
10
OAA67, ,
SPAT
0.5
9.5
103
1846
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
3.9
9.4
27
70
SPAT1097
SPAT
Recording of ECG
2.3
9.4
75
345
F71.1
ICD-10 Finland
Moderate mental retardation, significant impairment of behaviour requiring attention or treatment
30.3
9.4
12
*
3153X
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[PUHEEN KEHITYKSEN ERITYISVAIKEUS]
+∞
9.4
9
*
F95.9
ICD-10 Finland
Tic disorder, unspecified
10.8
9.3
17
16
ZXY59
NOMESCO Finland
2-person team, nurse-other special worker
13.8
9.2
15
11
ZYC01, ,
SPAT
1.6
9.2
224
1481
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.5
9.2
118
2009
IER05
NOMESCO Finland
Rehabilitative psychiatric group intervention, social skills
11.6
9.1
16
14
SPAT1377
SPAT
Polysomnography
3.3
9.1
33
101
OAB95, ,
SPAT
0.4
9.1
45
1076
OAA62, ,
SPAT
0.5
9.0
75
1470
Z72.9
ICD-10 Finland
Problem related to lifestyle, unspecified
37.0
9.0
11
*
Z10.0
ICD-10 Finland
Occupational health examination
0.4
9.0
51
1155
F40.2
ICD-10 Finland
Specific (isolated) phobias
3.9
9.0
26
68
H52.1
ICD-10 Finland
Myopia
2.1
8.9
80
386
G47.9
ICD-10 Finland
Sleep disorder, unspecified
2.7
8.9
46
173
GD1AA, ,
SPAT
0.5
8.9
72
1423
ICB01, ,
SPAT
3.6
8.9
28
78
OAB38, ,
SPAT
1.9
8.9
109
591
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.1
8.8
85
422
ZXY53
NOMESCO Finland
2-person team, doctor-social worker
10.8
8.8
16
15
F93.1
ICD-10 Finland
Phobic anxiety disorder of childhood
10.8
8.8
16
15
ICB07, ,
NOMESCO Finland
10.8
8.8
16
15
OAB72, ,
SPAT
3.1
8.7
36
119
IEP02
NOMESCO Finland
Child-centred family therapy
4.3
8.7
22
52
E03.89
ICD-10 Finland
Other specified hypothyroidism
3.0
8.7
37
125
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
0.5
8.7
75
1450
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
4.0
8.6
24
61
G50.1
ICD-10 Finland
Atypical facial pain
4.6
8.6
20
44
A06AD11
ATC
lactulose; oral
2.1
8.5
76
366
ZXY61
NOMESCO Finland
2-person team, special workers
9.1
8.5
17
19
T07
ICPC
Weight gain
2.9
8.5
39
137
R96
ICPC
Asthma
2.0
8.5
96
505
N05AL05
ATC
amisulpride; oral
20.2
8.5
12
6
Z2221
NOMESCO Finland
Medical doctor
1.6
8.4
262
1830
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.4
8.4
57
245
IEP01
NOMESCO Finland
Psychoeducation, family
6.8
8.4
20
30
IEY19
NOMESCO Finland
Psychiatric health counselling and guidance
4.9
8.4
18
37
C09CA06
ATC
candesartan; oral
1.7
8.4
148
898
T08
ICPC
Weight loss
3.0
8.4
35
117
3159X
ICD-9 Finland
Specific delays in development, Unspecified delay in development
+∞
8.3
8
*
SPAT1380
SPAT
Postpartum check-up
0.5
8.3
60
1238
ICZ04
NOMESCO Finland
Preparation of psychiatric treatment plan
7.1
8.3
19
27
F51.0
ICD-10 Finland
Nonorganic insomnia
1.6
8.2
241
1661
MA2JE
NOMESCO Finland
Ultrasound screening of fetal nuchal translucency
0.4
8.2
38
938
F23.91
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
14.6
8.2
13
9
R4140
NOMESCO Finland
Psychotherapy
4.4
8.2
20
46
H03AA01
ATC
levothyroxine sodium; systemic
1.7
8.1
157
976
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
8.1
171
1088
OAA10, ,
SPAT
0.3
8.1
27
776
F81.1
ICD-10 Finland
Specific spelling disorder
33.6
8.1
10
*
C02AC02
ATC
guanfacine; oral
33.6
8.1
10
*
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
4.1
8.1
22
55
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
8.0
449
3525
F98.00
ICD-10 Finland
Nonorganic enuresis nocturna
3.6
8.0
26
74
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.1
7.9
33
110
R06.0
ICD-10 Finland
Dyspnoea
1.6
7.9
199
1323
RS140, ,
NOMESCO Finland
6.6
7.9
19
29
F91.3
ICD-10 Finland
Oppositional defiant disorder
13.1
7.9
13
10
IAB01, ,
SPAT
6.1
7.9
20
33
U04
ICPC
Incontinence urine
3.2
7.8
30
95
UKC02
NOMESCO Finland
Cystoscopy
2.2
7.8
66
312
Z03
ICPC
Housing/neighbourhood problem
9.5
7.8
15
16
XA820, ,
NOMESCO Finland
7.0
7.8
18
26
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
7.8
391
3006
SAA02
NOMESCO Finland
Basic examination of mouth
1.6
7.8
1002
9139
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
7.8
181
1181
WZA00, ,
SPAT
2.1
7.7
70
340
F94.0
ICD-10 Finland
Elective mutism
15.1
7.7
12
8
H13
ICPC
Plugged feeling ear
1.7
7.7
149
926
F41.00
ICD-10 Finland
Moderate panic disorder
2.7
7.7
40
151
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
7.7
185
1216
F64.8
ICD-10 Finland
Other gender identity disorders
18.5
7.6
11
6
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
3.5
7.6
25
72
G47.2
ICD-10 Finland
Disorders of the sleep-wake schedule
8.9
7.5
15
17
3007
Kela drug reimbursment
Erenumab and fremanezumab
3.3
7.5
28
87
F90.1
ICD-10 Finland
Hyperkinetic conduct disorder
10.1
7.5
14
14
ZYA02
NOMESCO Finland
Contact at day ward in specialised medical care or in other intensive outpatient care setting
10.1
7.5
14
14
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
1.8
7.5
110
631
N02BF01
ATC
gabapentin; oral
2.0
7.5
76
385
Z91.5
ICD-10 Finland
Personal history of self-harm
7.2
7.5
17
24
WZC00
NOMESCO Finland
Treatment plan or consultation
1.4
7.5
470
3756
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.2
7.4
63
298
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.3
7.4
54
240
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.5
7.4
45
184
R42
ICD-10 Finland
Dizziness and giddiness
1.6
7.4
160
1024
OAA70, ,
SPAT
0.2
7.4
6
330
WVA30, ,
SPAT
2.3
7.4
53
234
SPAT1303
SPAT
Counselling and guidance related to growth and development
2.1
7.4
67
326
F45.0
ICD-10 Finland
Somatization disorder
8.4
7.3
15
18
N05AF05
ATC
zuclopenthixol; systemic
8.4
7.3
15
18
Z3229
NOMESCO Finland
Other healthcare associate professional
2.1
7.3
72
361
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.9
7.3
34
121
R02
ICPC
Shortness of breath/dyspnoea
1.8
7.3
122
728
F84.4
ICD-10 Finland
Overactive disorder associated with mental retardation and stereotyped movements
+∞
7.3
7
*
P73
ICPC
Affective psychosis
9.4
7.3
14
15
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
7.2
134
823
R63.4
ICD-10 Finland
Abnormal weight loss
2.8
7.2
34
122
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.0
7.2
20
51
T83
ICPC
Overweight
2.8
7.2
35
128
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
3.5
7.1
24
70
S22
ICPC
Nail symptom/complaint
1.9
7.1
82
435
G04BD08
ATC
solifenacin; oral
3.4
7.1
25
75
IHZ02, ,
SPAT
2.0
7.1
72
365
P20
ICPC
Memory disturbance
3.8
7.1
21
56
R45.1
ICD-10 Finland
Restlessness and agitation
12.1
7.1
12
10
ZXY58
NOMESCO Finland
2-person team, nurse-occupational therapist
12.1
7.1
12
10
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.7
7.1
125
758
ZXE22
NOMESCO Finland
Procedure duration at least 4 but less than 5 hours
8.8
7.1
14
16
F91.9
ICD-10 Finland
Conduct disorder, unspecified
8.8
7.1
14
16
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
8.8
7.1
14
16
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.4
7.0
48
207
A03FA02
ATC
cisapride; oral, rectal
2.4
7.0
48
207
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
4.2
7.0
18
43
L17
ICPC
Foot/toe symptom/complaint
1.4
7.0
316
2373
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
3.4
7.0
24
71
IBA03
NOMESCO Finland
Psychotherapy evaluation
2.9
7.0
32
113
SHA03
NOMESCO Finland
Stomatognathic treatment, demanding
2.3
7.0
51
227
N02CD01
ATC
erenumab; parenteral
4.4
7.0
17
39
SPAT1153
SPAT
Removal of sutures
1.6
6.9
196
1338
N94.6
ICD-10 Finland
Dysmenorrhoea, unspecified
2.2
6.9
56
261
R04
ICPC
Breathing problem other
2.4
6.8
44
185
R55
ICD-10 Finland
Syncope and collapse
1.9
6.8
83
449
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.7
6.8
122
743
IEY17
NOMESCO Finland
Neuropsychiatric coaching
40.3
6.8
8
*
F93.2
ICD-10 Finland
Social anxiety disorder of childhood
40.3
6.8
8
*
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
1.7
6.7
113
675
N06AA06
ATC
trimipramine; systemic
3.9
6.7
19
49
OAA46, ,
SPAT
3.3
6.7
24
73
R00.2
ICD-10 Finland
Palpitations
1.8
6.7
97
555
IAB05
NOMESCO Finland
Psychiatric consultation for gender identity assessment
22.6
6.7
9
*
N17
ICPC
Vertigo/dizziness
1.7
6.7
118
716
R06.5
ICD-10 Finland
Mouth breathing
1.8
6.7
97
556
H52.2
ICD-10 Finland
Astigmatism
2.5
6.6
41
169
IHZ05
NOMESCO Finland
Therapeutic conversation
3.7
6.6
20
54
Z36.0
ICD-10 Finland
Antenatal screening for chromosomal anomalies
0.4
6.6
27
706
RS220, ,
NOMESCO Finland
3.6
6.6
21
59
RT130, ,
NOMESCO Finland
12.3
6.6
11
9
OAA65, ,
SPAT
0.6
6.6
170
2450
SPAT1399
SPAT
Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.
0.3
6.6
21
615
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.9
6.5
77
412
ZYB05
NOMESCO Finland
Outreach service at patient’s workplace, school or occupational/school health care
10.1
6.5
12
12
R44.0
ICD-10 Finland
Auditory hallucinations
6.9
6.5
15
22
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.3
6.5
49
221
G43.9
ICD-10 Finland
Migraine, unspecified
1.7
6.5
111
667
XG466
NOMESCO Finland
Sleep oxymetry
3.7
6.5
20
55
F50.3
ICD-10 Finland
Atypical bulimia nervosa
5.4
6.5
18
34
IEY19, ,
SPAT
5.4
6.5
18
34
SCA03
NOMESCO Finland
Preventive oral health care, extensive
1.8
6.5
100
584
A13
ICPC
Concern/fear medical treatment
3.5
6.4
21
60
F41.01
ICD-10 Finland
Severe panic disorder
3.4
6.4
22
65
SPAT1262
SPAT
Handing over of treatment supplies
1.8
6.4
97
562
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.7
6.4
127
794
IEV99, ,
SPAT
7.4
6.4
14
19
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
3.8
6.4
19
51
H53.0
ICD-10 Finland
Amblyopia ex anopsia
3.1
6.4
26
86
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
2.8
6.3
30
108
RT250, ,
NOMESCO Finland
8.2
6.3
13
16
IHZ01, ,
SPAT
2.6
6.3
36
143
N88
ICPC
Epilepsy
6.0
6.3
16
27
Z73.8
ICD-10 Finland
Other problems related to life-management difficulty
3.2
6.3
24
76
L01
ICPC
Neck symptom/complaint
1.5
6.3
191
1322
N89
ICPC
Migraine
1.8
6.3
90
513
F33.0
ICD-10 Finland
Recurrent depressive disorder, current episode mild
3.0
6.3
27
92
N02CD03
ATC
fremanezumab; systemic
3.4
6.3
22
66
F33.31
ICD-10 Finland
Recurrent depression, severe episode of somatic syndrome
18.1
6.3
9
5
N03AG04
ATC
vigabatrin; oral
18.1
6.3
9
5
2990A
ICD-9 Finland
Psychoses with origin specific to childhood, Infantile autism[AUTISMUS INFANTILIS,TÄYDELLINEN OIREYHTYMÄ]
+∞
6.3
6
*
R46.8
ICD-10 Finland
Other symptoms and signs involving appearance and behaviour
26.8
6.2
8
*
181
Kela drug reimbursment
Retigabine and vigabatrin
26.8
6.2
8
*
A29
ICPC
General symptom/complaint other
1.7
6.2
120
745
S29
ICPC
Skin symptom/complaint other
1.5
6.2
217
1547
IAA02, ,
SPAT
5.1
6.2
18
36
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
6.2
309
2359
XKD00
NOMESCO Finland
Uroflowmetry
2.1
6.1
58
287
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
3.0
6.1
26
88
OAB44, ,
SPAT
1.5
6.1
208
1476
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
8.6
6.1
12
14
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.7
6.1
111
680
OAA64, ,
SPAT
0.5
6.0
62
1138
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
6.7
6.0
14
21
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
10.1
6.0
11
11
OAB76, ,
SPAT
2.2
6.0
48
222
P24
ICPC
Specific learning problem
2.8
6.0
28
100
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
471
1976
3.27
82.30
2.0
1.7
1.46
1.37
%
3.75
430
1810
244
754
3.80
67.73
1.7
1.6
1176.32
1121.90
nmol/l
0.41
192
582
587
3087
2.75
64.30
5.0
7.1
1.22
1.22
mmol/l
1.18
540
2914
313
1193
3.19
61.94
1.6
1.5
413.79
38254835.54
pmol/l
1.54
267
1077
395
1738
2.89
60.31
1.7
1.4
17.98
18.81
nmol/l
0.59
356
1580
623
3518
2.59
57.06
5.9
7.1
1.22
1.22
mmol/l
0.60
536
3123
531
2842
2.55
53.56
2.0
1.7
98.47
97.12
pmol/l
0.27
327
1626
1038
7734
3.45
52.10
5.4
4.0
14.54
14.46
pmol/l
0.55
960
7119
873
6114
2.55
45.90
6.6
6.8
83.31
78.39
u/l
1.71
810
5829
440
2322
2.41
43.83
2.5
2.7
2.35
2.36
mmol/l
0.50
404
2168
634
3963
2.26
41.81
3.1
2.7
66.82
68.54
nmol/l
0.91
601
3782
82
157
5.53
41.20
6.9
6.4
400.94
366.19
umol/l
1.15
71
146
1113
9068
3.94
39.88
12.6
9.7
139.83
139.53
mmol/l
5.64
1083
8830
1098
8884
3.63
39.50
6.7
4.7
1.84
1.75
mu/l
2.21
1055
8488
1023
7969
2.87
39.24
4.7
3.0
5.52
5.51
mmol/l
0.08
957
7531
1112
9089
3.86
38.89
12.6
9.7
3.86
3.90
mmol/l
6.56
1078
8815
402
2294
2.13
31.04
2.3
2.5
2.63
2.47
mg/l
1.15
342
2029
510
3190
2.04
30.63
3.5
3.6
28.76
30.24
u/l
0.47
485
3046
221
998
2.49
29.68
2.0
2.1
363.18
381.56
nmol/l
0.68
210
938
427
2542
2.05
29.06
3.1
3.8
8.49
9.28
mmol/l
1.79
357
2329
172
698
2.71
28.72
3.2
2.5
30.76
30.92
%
0.06
131
542
477
2989
1.98
27.83
4.8
5.7
38.89
38.25
g/l
2.01
430
2827
401
2394
2.01
26.62
2.7
2.8
54.62
55.31
u/l
0.18
356
2251
36
50
7.39
24.67
1.8
2.2
16.70
13.43
umol/l
0.73
36
50
559
3842
1.85
23.47
4.5
5.8
10.16
11.64
umol/l
2.08
500
3617
162
705
2.50
23.25
1.6
1.7
0.15
0.24
mg/l
3.25
56
328
905
7270
1.98
22.81
4.3
3.2
33.50
31.97
u/l
0.44
863
7047
318
1836
1.99
22.62
2.5
2.1
311.92
288.21
u/l
0.09
307
1771
143
597
2.58
22.35
3.7
4.2
—
—
—
0
0
836
9791
0.52
22.14
3.3
4.0
—
—
—
0
0
35
60
5.97
19.69
5.0
5.1
223.89
231.33
umol/l
0.03
18
33
53
1633
0.29
18.85
1.5
1.6
1131.23
965.95
mu/l
0.37
47
1430
824
6595
1.79
18.84
4.3
3.7
7.53
7.03
mm/h
0.76
757
6225
1138
10218
3.01
18.70
13.7
10.4
69.36
70.27
umol/l
1.02
1123
10076
632
4723
1.71
18.22
4.7
5.0
6.06
6.21
mmol/l
0.86
583
4278
73
243
3.13
17.35
1.7
1.6
449.91
352.97
mu/l
1.03
60
197
1132
10222
2.74
16.76
11.0
8.6
29.88
27.87
u/l
2.03
1104
9986
178
926
2.08
16.45
2.0
1.7
379.62
305.08
mu/l
1.54
146
829
141
671
2.25
16.33
3.7
5.3
5.19
5.07
kpa
1.11
133
647
106
458
2.44
15.30
2.9
4.1
1.22
1.22
mmol/l
0.35
87
398
487
3525
1.64
14.89
1.5
1.5
1.41
1.83
u/ml
0.30
123
916
129
620
2.21
14.55
3.6
5.4
0.96
1.00
mmol/l
0.05
83
426
189
1054
1.94
14.27
5.1
8.0
1.14
1.16
mmol/l
0.56
177
993
133
662
2.13
13.72
2.8
3.5
4.97
4.81
pmol/l
1.06
117
606
445
3211
1.61
13.42
1.9
1.8
1.51
1.37
mmol/l
0.99
374
2941
75
1689
0.41
13.37
1.5
1.6
3.41
3.54
ratio
0.37
47
1201
890
7593
1.65
12.94
4.6
3.6
35.73
36.09
mmol/mol
0.54
819
7337
29
1019
0.27
12.76
1.4
1.4
—
—
—
0
0
697
5657
1.55
12.13
3.5
3.3
64.93
70.75
ug/l
0.72
640
5416
699
5682
1.55
12.03
11.8
9.5
3.69
3.89
e9/l
2.23
621
4916
136
720
2.00
11.86
3.0
3.5
0.24
0.23
g/l
0.92
123
679
18
799
0.21
11.62
1.6
1.5
1.23
1.14
ratio
0.18
12
482
18
799
0.21
11.62
1.6
1.5
1.65
1.20
ratio
0.82
12
486
18
799
0.21
11.62
1.6
1.5
0.77
0.94
ratio
2.14
12
482
200
1221
1.76
11.16
2.2
2.4
15.14
15.24
umol/l
0.06
184
1144
47
157
3.07
11.16
1.5
4.3
31.15
35.61
umol/l
0.98
40
151
19
785
0.23
10.94
1.5
1.5
—
—
—
0
0
186
1122
1.78
10.80
2.1
2.4
2.60
2.50
g/l
1.77
167
1041
169
992
1.82
10.75
2.1
2.5
24.57
24.57
%
0.00
154
930
972
8626
1.65
10.56
4.2
3.3
4.58
4.59
mmol/l
0.15
918
8331
972
8632
1.65
10.46
4.4
3.4
2.83
2.79
mmol/l
0.71
912
8298
185
1125
1.76
10.43
4.8
5.5
0.83
0.82
mmol/l
0.50
174
1080
60
1337
0.42
10.23
1.5
1.5
3.44
3.38
mmol/l
0.13
37
867
908
7961
1.57
10.02
3.5
2.9
1.34
1.20
mmol/l
4.28
849
7626
309
2177
1.56
9.74
2.9
2.4
12.73
162.44
ng/l
0.60
140
850
54
210
2.64
9.74
1.4
1.4
14.05
13.37
u/l
0.06
40
183
170
1032
1.75
9.61
1.9
2.3
2.37
2.40
mmol/l
2.50
147
906
99
507
2.04
9.45
1.5
1.8
3.23
3.82
mg/l
0.49
83
341
961
8579
1.59
9.36
4.1
3.3
1.32
1.39
mmol/l
8.24
904
8250
946
8438
1.56
9.00
10.4
8.1
105.43
103.69
ml/min/173m2
2.05
829
7265
181
1145
1.68
8.79
2.3
2.3
10.64
13.13
nmol/l
2.75
155
1075
15
14
10.83
8.30
1.0
1.0
—
—
—
0
0
41
151
2.77
8.24
1.5
1.5
6.82
6.37
umol/l
0.26
35
138
879
9640
0.67
8.07
16.2
12.5
334.78
335.09
g/l
0.45
872
9577
84
443
1.96
7.42
4.3
5.6
56.44
70.49
ng/l
2.00
72
416
341
2582
1.45
7.27
3.3
3.1
0.00
0.00
estimate
1.08
146
1018
398
3107
1.42
7.16
1.6
1.5
1.87
2.00
g/l
1.36
236
1991
122
749
1.70
6.60
1.7
1.7
7.82
6.98
u/l
0.39
100
579
12
471
0.25
6.39
1.2
1.3
—
—
—
0
0
162
1085
1.57
6.19
1.9
1.8
—
—
—
0
0
66
343
1.98
6.12
1.8
1.6
0.29
0.37
nmol/l
0.92
55
283
31
735
0.41
6.11
1.7
1.8
—
—
—
0
0
352
4372
0.72
5.94
1.8
1.9
—
—
—
0
0
24
80
3.04
5.82
2.4
1.6
91.50
92.02
%
0.23
24
80
83
477
1.79
5.67
4.4
5.7
9.60
9.64
kpa
0.07
77
462
199
1423
1.48
5.58
4.1
4.7
5.23
12.16
mg/mmol
2.19
116
1038
29
671
0.42
5.40
1.4
1.6
59.55
59.48
ug/l
0.00
29
671
307
2397
1.38
5.25
3.1
2.8
1.02
1.72
kg/l
0.50
204
1458
227
1686
1.43
5.20
2.6
2.6
7.51
8.67
e6/l
0.42
207
1534
129
857
1.56
5.11
4.1
7.2
1.57
1.25
mmol/l
0.64
110
717
140
951
1.53
5.02
2.9
3.4
541.30
676.23
ng/l
0.14
94
705
41
193
2.16
4.98
1.4
1.6
0.52
0.52
e9/l
0.05
41
193
219
1641
1.41
4.75
1.4
1.3
22.87
18.96
iu/ml
0.20
36
401
153
1072
1.49
4.74
1.3
1.2
77.85
145.00
u/ml
1.52
54
392
41
787
0.50
4.61
1.4
1.7
—
—
—
0
0
13
28
4.68
4.37
1.5
1.3
80.77
83.54
nmol/24h
0.04
13
28
196
2568
0.72
4.35
2.5
2.5
—
—
—
0
0
59
334
1.80
4.30
1.8
1.5
—
—
—
0
0
1172
11379
2.04
4.24
20.9
15.5
268.64
260.50
e9/l
4.44
1144
11136
28
121
2.34
4.19
1.6
1.5
0.96
1.40
promille
0.86
19
93
1172
11387
2.02
4.10
20.8
15.4
88.21
88.53
fl
1.54
1155
11291
1172
11389
2.01
4.07
21.2
15.8
41.44
42.34
%
0.80
1155
11288
1172
11390
2.01
4.05
20.8
15.4
4.73
4.69
e12/l
2.19
1145
11136
318
2588
1.31
3.99
3.5
3.0
108.14
48.16
e6/l
0.37
258
1900
1172
11395
1.99
3.97
21.0
15.6
139.44
138.90
g/l
0.70
1155
11298
1172
11400
1.98
3.88
21.0
15.5
6.70
6.74
e9/l
0.29
1144
11137
95
629
1.55
3.85
3.4
2.4
—
—
—
0
0
40
208
1.95
3.80
1.6
2.5
135.57
198.59
ug/l
0.65
33
195
47
260
1.84
3.72
1.9
2.3
—
—
—
0
0
250
1986
1.33
3.70
2.5
3.2
120.37
111.44
ug/g
0.16
157
1621
40
717
0.54
3.65
2.1
2.0
—
—
—
0
0
111
771
1.48
3.62
2.1
1.7
—
—
—
0
0
1054
10043
1.39
3.52
11.6
10.4
19.20
20.89
mg/l
1.00
762
7719
107
744
1.48
3.47
2.1
1.7
—
—
—
0
0
53
312
1.73
3.44
2.9
6.5
0.62
0.61
%
0.07
53
312
193
1492
1.35
3.43
1.3
1.3
4.73
6.01
u/ml
0.18
76
584
135
985
1.42
3.41
1.9
4.1
6.01
6.66
umol/l
0.31
111
824
77
501
1.57
3.40
1.6
1.4
—
—
—
0
0
98
674
1.49
3.36
2.3
2.3
9.35
16.08
au/ml
—
6
93
343
4029
0.79
3.30
2.9
2.8
—
—
estimate
—
0
0
138
1017
1.40
3.29
1.1
1.1
—
—
—
0
0
54
325
1.69
3.25
1.8
2.2
2.25
3.88
iu/l
1.97
27
150
40
678
0.58
3.03
1.6
1.4
—
—
—
0
0
54
848
0.62
3.02
1.3
1.3
262.06
244.85
miu/ml
0.08
16
422
14
52
2.71
2.89
1.0
1.4
31.93
32.31
pg
0.15
14
52
6
9
6.69
2.87
3.3
1.6
31.83
15.83
nmol/l
—
6
9
177
2209
0.77
2.72
2.4
2.3
—
—
—
0
0
25
125
2.02
2.71
3.0
4.9
4.93
6.21
pmol/l
0.93
25
125
58
375
1.57
2.68
1.4
1.4
—
—
—
0
0
35
198
1.79
2.65
1.8
1.5
315.80
340.29
ug/g
0.21
15
103
115
858
1.38
2.59
1.7
1.6
11.51
13.09
iu/l
0.35
95
680
164
2051
0.77
2.56
2.5
2.3
—
—
—
0
0
44
269
1.66
2.56
2.8
3.0
67.38
105.15
ng/l
0.75
37
220
8
208
0.38
2.42
2.1
1.6
—
—
—
0
0
361
4106
0.83
2.37
2.8
2.6
—
—
—
0
0
61
412
1.51
2.35
1.5
1.7
4.45
9.35
u/ml
0.84
13
116
16
329
0.48
2.32
1.6
1.5
—
—
—
0
0
17
79
2.17
2.25
1.2
1.2
102.00
122.77
pmol/l
1.02
17
79
20
102
1.98
2.11
1.4
1.3
—
—
—
0
0
341
3861
0.84
2.08
2.7
2.5
—
—
—
0
0
17
82
2.09
2.07
1.4
1.3
—
—
—
0
0
9
32
2.82
2.00
1.6
1.3
8.89
9.42
u/l
—
9
26
56
388
1.46
1.95
1.1
1.1
1.57
6.07
eliau/ml
—
7
62
8
28
2.87
1.86
1.1
1.3
—
—
—
0
0
17
87
1.97
1.80
1.4
1.2
78.14
36.93
u/l
0.24
17
79
9
36
2.51
1.74
1.6
1.2
72.67
69.17
u/l
—
9
29
5
13
3.86
1.71
1.6
1.4
—
—
—
0
0
261
2269
1.19
1.71
3.5
2.9
0.24
0.28
e6/l
0.17
199
1598
14
265
0.52
1.66
1.5
1.2
—
—
—
0
0
110
876
1.28
1.65
2.5
2.9
10.22
10.38
g/l
0.23
100
812
11
49
2.26
1.63
1.0
1.5
—
—
—
0
0
11
49
2.26
1.63
1.0
1.5
—
—
—
0
0
11
49
2.26
1.63
1.0
1.5
—
—
—
0
0
115
928
1.26
1.56
1.3
1.3
141.07
345.67
u/ml
1.43
105
857
18
100
1.81
1.53
1.4
1.5
—
—
—
0
0
5
15
3.34
1.52
1.8
3.7
38.20
175.13
ng/l
—
5
15
36
243
1.50
1.48
1.6
1.8
—
—
—
0
0
11
216
0.50
1.48
1.5
1.7
7.21
7.55
mmol/l
0.36
11
209
625
5859
1.14
1.45
4.4
3.6
282.50
1074.71
e6/l
0.54
12
66
75
579
1.31
1.44
1.9
1.8
33.55
36.69
nmol/l
0.64
75
570
69
527
1.33
1.43
6.9
10.4
1.01
0.30
mmol/l
0.72
50
436
6
23
2.62
1.36
1.0
1.1
—
—
—
0
0
6
23
2.62
1.36
2.0
2.2
—
—
—
0
0
5
17
2.95
1.36
1.4
1.5
1.15
1.19
mmol/l
—
5
17
66
506
1.32
1.35
1.6
1.9
—
—
—
0
0
417
3824
1.14
1.33
3.1
2.8
0.00
0.01
estimate
1.56
116
917
14
76
1.85
1.30
1.1
1.1
—
—
—
0
0
5
19
2.64
1.21
3.2
1.6
11.00
15.63
u/l
—
5
19
125
1051
1.21
1.20
2.6
2.6
1.09
1.08
ug/l
0.03
106
955
14
79
1.78
1.17
1.0
1.3
1.51
1.88
mmol/l
1.56
14
74
31
215
1.45
1.16
2.5
2.3
11.04
9.32
mg/l
0.97
31
203
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
0
34
0.00
1.16
0.0
1.1
—
1.30
—
0
34
18
110
1.65
1.15
1.2
1.4
—
—
—
0
0
15
87
1.73
1.15
1.1
1.2
—
32.17
—
0
6
152
1309
1.18
1.14
2.5
2.6
9462.79
7617.82
u/l
0.12
37
514
17
103
1.66
1.13
1.5
1.4
5.22
5.93
u/ml
0.08
11
64
8
41
1.96
1.09
1.9
1.4
207.13
182.34
u/l
—
8
41
7
32
2.19
1.08
4.1
3.4
57.14
168.93
ug/l
—
7
32
15
89
1.69
1.07
1.1
1.3
0.17
0.16
nmol/l
—
10
72
37
270
1.38
1.07
1.7
1.9
—
—
—
0
0
945
9185
1.13
1.00
17.1
12.9
13.11
13.08
%
0.53
927
9078
12
68
1.77
1.00
1.2
1.2
—
44.33
—
0
6
0
30
0.00
0.97
0.0
1.2
—
18.14
—
0
7
18
116
1.56
0.96
1.1
1.1
—
—
—
0
0
22
149
1.48
0.95
1.1
1.2
—
—
—
0
0
0
32
0.00
0.95
0.0
1.3
—
32.00
—
0
5
36
268
1.35
0.95
1.1
2.6
3.41
3.50
mmol/l
0.56
36
255
7
37
1.90
0.94
1.0
1.1
—
—
—
0
0
17
109
1.57
0.93
1.2
1.4
—
—
—
0
0
17
109
1.57
0.93
1.2
1.4
—
—
—
0
0
24
338
0.70
0.93
1.3
1.6
—
—
—
0
0
20
134
1.50
0.92
1.0
1.3
—
168.00
—
0
5
5
102
0.49
0.89
1.0
1.1
2330.20
1455.37
miu/ml
—
5
102
148
1301
1.16
0.89
3.6
2.6
4.03
3.10
e6/l
0.43
84
580
13
79
1.65
0.88
1.1
1.6
—
—
—
0
0
16
103
1.56
0.87
1.1
1.5
—
—
—
0
0
26
187
1.40
0.85
2.2
2.9
47.72
24.31
mu/l
0.48
20
174
35
265
1.33
0.85
1.3
1.3
—
—
—
0
0
23
320
0.71
0.84
1.0
1.1
—
—
—
0
0
16
104
1.54
0.84
1.2
1.4
—
—
—
0
0
25
179
1.40
0.84
1.2
1.3
—
—
—
0
0
6
111
0.54
0.83
1.2
1.2
—
—
—
0
0
6
112
0.53
0.83
1.0
1.3
—
241.25
—
0
24
135
1186
1.16
0.83
2.8
2.9
220.76
784.70
ng/l
1.86
65
576
11
65
1.70
0.82
1.4
1.1
—
—
—
0
0
16
105
1.53
0.81
1.2
1.4
—
—
—
0
0
16
105
1.53
0.81
1.2
1.4
—
—
—
0
0
97
832
1.18
0.81
2.1
2.4
26.67
92.68
u/l
0.58
78
693
0
24
0.00
0.79
0.0
2.3
—
82.67
—
0
24
5
98
0.51
0.78
1.2
1.2
—
—
—
0
0
5
98
0.51
0.78
1.2
1.2
—
—
—
0
0
5
98
0.51
0.78
1.2
1.2
—
—
—
0
0
5
99
0.50
0.78
1.2
1.2
—
—
—
0
0
0
27
0.00
0.77
0.0
1.0
—
8.40
—
0
5
5
24
2.09
0.74
1.0
1.8
—
—
—
0
0
5
24
2.09
0.74
1.0
1.8
—
—
—
0
0
19
133
1.43
0.73
1.2
1.2
96.11
95.77
%
0.02
19
127
75
879
0.84
0.73
1.5
1.4
—
—
—
0
0
5
25
2.00
0.72
1.0
1.8
—
—
—
0
0
30
389
0.76
0.72
2.2
2.0
—
—
—
0
0
52
426
1.23
0.71
1.4
1.3
—
—
—
0
0
26
194
1.35
0.71
1.4
1.5
—
—
—
0
0
31
399
0.77
0.71
3.8
2.9
17.75
5.60
umol/l
0.48
21
313
22
160
1.38
0.70
1.4
1.4
—
—
—
0
0
18
251
0.71
0.70
1.0
1.1
1.77
2.29
eliau/ml
—
10
114
26
196
1.33
0.67
1.3
1.3
2.62
5.30
u/ml
0.83
13
74
17
119
1.43
0.67
1.1
1.3
74.26
189.33
pmol/l
4.75
17
119
5
95
0.52
0.66
1.2
1.2
—
—
—
0
0
30
232
1.30
0.66
2.0
1.6
—
—
—
0
0
16
111
1.45
0.66
2.0
1.5
—
—
—
0
0
7
44
1.59
0.65
1.7
1.9
—
—
—
0
0
26
198
1.32
0.64
1.3
1.3
4.92
3.90
u/ml
0.16
13
92
38
305
1.25
0.64
1.8
1.8
3.54
7.60
ug/l
2.02
31
260
49
588
0.83
0.63
1.9
2.0
0.48
0.56
ug/l
0.43
25
207
36
288
1.26
0.62
1.1
2.6
334.67
419.77
mg/l
1.44
36
276
11
164
0.67
0.62
1.5
4.2
5.53
7.80
u/ml
0.46
11
159
20
147
1.37
0.61
2.0
1.7
—
—
—
0
0
176
1916
0.90
0.60
1.6
1.6
—
—
—
0
0
57
483
1.19
0.59
2.2
2.4
90.65
85.42
ml/min/173m2
0.45
23
179
6
35
1.72
0.57
1.0
1.6
—
—
—
0
0
6
35
1.72
0.57
1.0
1.6
—
—
—
0
0
6
35
1.72
0.57
1.0
1.6
—
—
—
0
0
6
35
1.72
0.57
1.0
1.6
—
—
—
0
0
15
107
1.41
0.55
3.4
6.3
10.88
9.79
mg/l
—
9
92
8
124
0.64
0.54
1.0
1.0
—
—
—
0
0
145
1580
0.91
0.51
2.8
2.6
315.51
323.60
umol/l
0.50
113
1481
6
40
1.50
0.51
5.3
1.5
—
—
—
0
0
25
197
1.27
0.51
4.8
3.2
1.38
2.95
index
0.98
13
114
38
455
0.83
0.51
1.2
1.3
—
—
—
0
0
203
1891
1.09
0.50
2.1
2.4
0.74
1.03
mg/l
1.42
134
1304
35
289
1.22
0.49
10.0
12.0
17.02
16.55
%
0.53
35
275
7
46
1.52
0.48
1.4
2.2
106.14
105.74
mmol/l
—
7
46
522
5041
1.06
0.47
3.5
3.1
0.00
2.78
estimate
0.80
148
1048
8
119
0.67
0.46
1.3
1.3
—
—
—
0
0
38
449
0.84
0.45
1.8
1.6
0.01
0.18
iu/ml
—
7
79
523
5057
1.06
0.45
3.5
3.1
0.00
0.00
estimate
-0.00
141
1017
10
69
1.45
0.44
1.1
1.4
1.99
1.37
nmol/l
—
10
58
14
104
1.35
0.43
1.1
1.8
0.00
0.00
g/l
-0.00
14
98
321
3062
1.07
0.43
2.8
2.5
0.00
0.01
estimate
1.34
128
888
8
58
1.38
0.41
1.0
1.1
218.99
215.68
iu/ml
—
8
58
114
1045
1.10
0.41
2.2
3.7
29.92
29.62
s
0.23
109
1027
10
138
0.72
0.40
4.2
2.2
—
—
—
0
0
222
2097
1.07
0.40
3.8
5.0
96.01
92.21
%
1.69
211
2061
8
61
1.31
0.39
1.1
2.1
—
—
—
0
0
77
694
1.12
0.39
2.4
4.8
210.43
238.84
u/l
1.69
72
668
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
9
67
1.35
0.38
1.4
1.3
68.11
73.25
umol/l
—
9
67
25
206
1.22
0.38
1.1
1.1
—
—
—
0
0
5
37
1.35
0.37
1.0
1.2
—
—
—
0
0
15
116
1.30
0.37
2.3
1.6
—
—
—
0
0
18
143
1.26
0.37
1.2
1.7
—
—
—
0
0
6
43
1.40
0.35
1.5
2.3
1.18
1.19
mmol/l
—
6
43
25
209
1.20
0.34
2.2
1.3
—
—
—
0
0
15
187
0.80
0.32
1.3
1.3
—
—
—
0
0
15
187
0.80
0.32
1.3
1.3
—
—
—
0
0
47
417
1.13
0.32
1.1
1.1
4.54
9.00
u/ml
1.53
28
218
14
175
0.80
0.31
4.6
3.0
20.37
25.84
mg/l
—
7
119
52
578
0.89
0.30
1.7
1.8
—
—
—
0
0
514
5011
1.04
0.30
3.5
3.1
0.00
0.00
estimate
0.50
147
1070
10
75
1.34
0.30
1.0
1.0
0.46
2.08
u/ml
—
10
75
7
55
1.27
0.30
1.3
1.3
—
—
—
0
0
29
250
1.16
0.29
2.1
1.6
—
—
—
0
0
8
65
1.23
0.27
1.0
1.1
—
—
—
0
0
5
73
0.68
0.26
2.6
1.8
—
—
—
0
0
5
75
0.66
0.26
1.2
2.2
25.56
33.48
mg/l
—
5
67
47
426
1.11
0.24
2.3
2.0
9.63
4.88
iu/ml
0.34
12
90
45
496
0.90
0.24
1.4
1.5
200.67
201.02
u/ml
0.00
12
289
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
10
126
0.79
0.24
7.7
11.9
0.18
0.30
iu/ml
—
5
65
33
370
0.89
0.24
1.6
1.6
—
32.77
—
0
6
13
106
1.23
0.23
1.1
1.1
—
—
—
0
0
5
39
1.28
0.23
1.8
1.5
—
—
—
0
0
26
295
0.88
0.22
1.0
1.1
—
—
—
0
0
19
220
0.86
0.21
1.0
1.2
—
—
—
0
0
30
267
1.13
0.21
1.1
2.7
352.38
851.25
e6/l
0.32
24
198
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
3.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
142
1357
1.05
0.21
3.6
2.6
1.53
0.98
e6/l
0.51
81
635
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
26
291
0.89
0.19
1.0
1.1
—
—
—
0
0
11
90
1.22
0.19
1.7
1.5
10.47
9.75
umol/l
0.18
11
85
7
59
1.19
0.18
1.0
1.2
—
—
—
0
0
5
67
0.74
0.17
1.6
1.2
3.18
8.46
u/ml
—
5
58
17
148
1.15
0.16
2.7
1.3
—
—
—
0
0
25
225
1.11
0.16
1.1
1.1
200.00
188.23
iu/ml
—
7
71
29
265
1.10
0.14
1.1
2.7
9.00
18.62
e6/l
0.59
21
184
50
532
0.94
0.14
1.6
1.3
—
—
—
0
0
68
646
1.06
0.14
1.2
1.2
2.46
2.69
u/ml
0.09
41
381
54
571
0.94
0.13
1.2
1.2
1.25
2.78
u/ml
1.74
34
346
48
454
1.06
0.11
1.1
1.1
2.76
5.92
u/ml
1.08
31
260
19
172
1.11
0.11
1.3
1.2
1.41
5.84
u/ml
1.00
11
74
62
593
1.05
0.10
1.1
1.2
4.07
7.45
u/ml
1.10
38
383
5
47
1.06
0.09
1.2
1.2
5.59
1.97
u/ml
—
5
47
5
48
1.04
0.09
1.2
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
64
0.78
0.08
1.0
1.1
—
—
—
0
0
6
75
0.80
0.07
1.2
2.2
18.20
30.37
mg/l
—
6
66
60
579
1.04
0.07
1.1
1.1
0.75
0.87
u/ml
0.13
31
309
12
109
1.10
0.06
2.3
1.9
—
—
—
0
0
27
257
1.05
0.05
2.3
4.6
2.17
6.27
ug/l
1.36
18
179
12
129
0.93
0.03
1.0
1.1
—
—
—
0
0
39
380
1.03
0.02
2.6
5.6
3.48
3.19
g/l
0.85
34
368
40
409
0.98
0.02
1.1
1.1
0.28
0.35
u/ml
0.13
20
150
13
123
1.06
0.01
1.2
2.3
—
—
—
0
0
12
126
0.95
0.01
1.0
1.1
—
—
—
0
0
14
146
0.96
0.01
2.9
1.6
—
—
—
0
0
12
114
1.05
0.00
2.2
3.2
—
—
—
0
0
13
124
1.05
0.00
1.5
1.6
908.50
17753.33
e6/l
—
8
89
11
109
1.01
0.00
1.2
1.2
—
—
—
0
0
11
110
1.00
0.00
1.2
1.2
—
—
—
0
0
76
761
1.00
0.00
2.6
2.6
21.76
23.09
%
0.16
15
156
12
123
0.97
0.00
1.2
1.5
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
2.69
—
0
9
5
59
0.85
0.00
13.8
5.0
0.60
0.80
index
—
5
59
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.7
—
9.64
—
0
7
5
55
0.91
-0.00
1.6
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
8
87
0.92
-0.00
4.9
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
26.75
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
8048.17
—
0
6
6
62
0.97
-0.00
1.5
1.2
6.50
3.25
u/ml
—
6
52
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: F5_AUTISM – Autism
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).